FDA approves AbbVie's Mavyret for acute hepatitis C, expanding its use to patients 3 and older with or without cirrhosis ...

The charts of all patients with HCV infection were reviewed in detail. Interviews were conducted to obtain further information about prior medical interventions, prior hepatitis infections ...

Private hospitals in Tamil Nadu face Hepatitis B vaccine shortage, impacting vaccination of high-risk adults and healthcare ...

Competing hepatitis C combination drugs from AbbVie and Gilead are now approved in the EU, as the companies aim to treat patients who cannot be cured with established regimens. AbbVie’s Maviret ...

Dozens of people were struck down during a hepatitis outbreak which has now been linked to a mystery supermarket item after ...

Mavyret marks the first and only direct-acting antiviral approved to treat both acute and chronic hepatitis C virus ...

New, successful treatments are being introduced to help treat hepatitis C patients, however, various barriers could block many, including Black Americans, from receiving it. It is estimated that there ...

The U.S. Food and Drug Administration (FDA) approved a label expansion for AbbVie Inc’s (NYSE:ABBV) Mavyret ...

The health and human services secretary has repeatedly claimed children need dozens more vaccines than they actually do.

Kathy Seward MacKay lost her husband in 1997 because of tainted blood-clotting products. She’s worried about history ...

Three of the 16 patients were started on MMF for reasons other than AIH. AI: Autoimmune; AIH: Autoimmune hepatitis; AST: Aspartate aminotransferase; AZA: Azathioprine; MMF: Mycophenolate mofetil ...